Published in J Child Adolesc Psychopharmacol on December 01, 2009
Public stigma associated with psychosis risk syndrome in a college population: implications for peer intervention. Psychiatr Serv (2013) 0.83
The 'at-risk mental state' for psychosis in adolescents: clinical presentation, transition and remission. Child Psychiatry Hum Dev (2014) 0.78
Smell identification in individuals at clinical high risk for schizophrenia. Psychiatry Res (2014) 0.77
Evaluation and treatment of children and adolescents with psychotic symptoms. Curr Psychiatry Rep (2012) 0.75
A case report of cognitive behavioural therapy for social anxiety in an ultra-high risk patient. Early Interv Psychiatry (2013) 0.75
Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry (1997) 41.93
Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry (2008) 9.54
Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull (2003) 7.11
Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet (1994) 4.28
Reduced amygdala response to fearful expressions in children and adolescents with callous-unemotional traits and disruptive behavior disorders. Am J Psychiatry (2008) 3.69
Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res (2004) 3.55
Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ (1994) 3.33
The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr Bull (2003) 2.67
Continuities and discontinuities in psychopathology between childhood and adult life. J Child Psychol Psychiatry (2006) 2.64
Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr Bull (2005) 2.50
The psychosis prodrome in adolescent patients viewed through the lens of DSM-IV. J Child Adolesc Psychopharmacol (2005) 1.72
Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia. Arch Gen Psychiatry (2008) 1.70
Neurocognitive performance and functional disability in the psychosis prodrome. Schizophr Res (2006) 1.67
The initial prodrome in schizophrenia: searching for naturalistic core dimensions of experience and behavior. Schizophr Bull (2000) 1.65
Impaired attention as an endophenotype for molecular genetic studies of schizophrenia. Am J Med Genet (2001) 1.51
Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia? J Psychiatry Neurosci (2005) 1.49
Infants at risk for schizophrenia: sequelae of a genetic neurointegrative defect. A review and replication analysis of pandysmaturation in the Jerusalem Infant Development Study. Arch Gen Psychiatry (1992) 1.49
The relations among putative biorisk markers in schizotypal adolescents: minor physical anomalies, movement abnormalities, and salivary cortisol. Biol Psychiatry (2006) 1.46
The ABC Schizophrenia Study: a preliminary overview of the results. Soc Psychiatry Psychiatr Epidemiol (1998) 1.44
Phenomenology and diagnosis of bipolar disorder in children, adolescents, and adults: complexities and developmental issues. Dev Psychopathol (2006) 1.42
Social adjustment of adolescents at risk for schizophrenia: the Jerusalem Infant Development Study. J Am Acad Child Adolesc Psychiatry (2000) 1.39
Movement abnormalities predict conversion to Axis I psychosis among prodromal adolescents. J Abnorm Psychol (2007) 1.38
Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome. Schizophr Res (2006) 1.38
Significance and meaning of neurological signs in schizophrenia: two decades later. Schizophr Bull (2005) 1.34
Precursors to schizophrenia: do biological markers have specificity? Can J Psychiatry (1999) 1.32
The phenomenological critique and self-disturbance: implications for ultra-high risk ("prodrome") research. Schizophr Bull (2007) 1.16
Trajectory to a first episode of psychosis: a qualitative research study with families. Early Interv Psychiatry (2007) 1.14
Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis. Schizophr Res (2008) 1.13
Detection and management of comorbidity in patients with schizophrenia. Psychiatr Clin North Am (2003) 1.08
Hierarchical diagnosis in chronic schizophrenia: a clinical study of co-occurring syndromes. Schizophr Bull (2000) 1.04
Comorbid schizophrenia and substance abuse: a review of epidemiology and course. Am J Addict (2006) 1.03
Neuromotor development in nocturnal enuresis. Dev Med Child Neurol (2006) 0.94
School teacher ratings predictive of psychiatric outcome 25 years later. Br J Psychiatry Suppl (1998) 0.91
The diagnosis of prepsychotic schizophrenia. Lancet (1959) 0.88
Treatment histories of patients with a syndrome putatively prodromal to schizophrenia. Psychiatr Serv (2002) 0.88
Evidence for separate diseases?: Stages of one disease or different combinations of symptom dimensions? Eur Arch Psychiatry Clin Neurosci (2008) 0.87
Early neurobehavioral deficits as phenotypic indicators of the schizophrenia genotype and predictors of later psychosis. Am J Med Genet (2001) 0.84
Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry (2006) 11.25
Safety and tolerability of methylphenidate in preschool children with ADHD. J Am Acad Child Adolesc Psychiatry (2006) 10.19
Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS). J Am Acad Child Adolesc Psychiatry (2006) 10.00
Stimulant-related reductions of growth rates in the PATS. J Am Acad Child Adolesc Psychiatry (2006) 9.98
Pharmacogenetics of methylphenidate response in preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry (2006) 9.85
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations. Pain (2013) 2.58
The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up. J Am Acad Child Adolesc Psychiatry (2013) 2.48
Treatment for Adolescents with Depression Study (TADS): safety results. J Am Acad Child Adolesc Psychiatry (2006) 2.45
The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial. J Am Acad Child Adolesc Psychiatry (2009) 2.13
Computerized experience sampling method (ESMc): assessing feasibility and validity among individuals with schizophrenia. J Psychiatr Res (2005) 2.06
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biol Psychiatry (2010) 1.99
Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder. J Am Acad Child Adolesc Psychiatry (2007) 1.78
Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: a meta-analytic comparison of randomized controlled trials. Schizophr Res (2012) 1.68
Short sleep duration as a risk factor for hypercholesterolemia: analyses of the National Longitudinal Study of Adolescent Health. Sleep (2010) 1.59
Resting neural activity distinguishes subgroups of schizophrenia patients. Biol Psychiatry (2004) 1.51
Earlier parental set bedtimes as a protective factor against depression and suicidal ideation. Sleep (2010) 1.48
Paternal age and sporadic schizophrenia: evidence for de novo mutations. Am J Med Genet (2002) 1.47
Diagnosis and treatment of a patient with both psychotic and obsessive-compulsive symptoms. Am J Psychiatry (2010) 1.46
Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters (TASA) Study. J Am Acad Child Adolesc Psychiatry (2009) 1.44
Effect of acute alcohol use on the lethality of suicide attempts in patients with mood disorders. J Psychiatr Res (2009) 1.33
Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD. J Am Acad Child Adolesc Psychiatry (2003) 1.29
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement. J Clin Psychiatry (2010) 1.27
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophr Res (2011) 1.17
Insomnia and sleep duration as mediators of the relationship between depression and hypertension incidence. Am J Hypertens (2009) 1.17
Use of Palm computer as an adjunct to cognitive-behavioural therapy with an ultra-high-risk patient: a case report. Early Interv Psychiatry (2008) 1.17
Odor identification, eye tracking and deficit syndrome schizophrenia. Biol Psychiatry (2002) 1.15
Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis. Schizophr Res (2008) 1.13
A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD. J Atten Disord (2006) 1.11
Families' experience with seeking treatment for recent-onset psychosis. Psychiatr Serv (2009) 1.07
Suicidal events in the Treatment for Adolescents With Depression Study (TADS). J Clin Psychiatry (2009) 1.07
Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall. J Am Acad Child Adolesc Psychiatry (2003) 1.06
Stigma in families of individuals in early stages of psychotic illness: family stigma and early psychosis. Early Interv Psychiatry (2009) 1.06
Comparison of clinical and research assessments of diagnosis, suicide attempt history and suicidal ideation in major depression. J Affect Disord (2008) 1.06
Later paternal age and sex differences in schizophrenia symptoms. Schizophr Res (2009) 1.05
Attention deficit hyperactivity disorder in preschool children. Child Adolesc Psychiatr Clin N Am (2008) 1.02
Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol (2007) 1.02
Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol (2007) 1.01
Childhood trauma and prodromal symptoms among individuals at clinical high risk for psychosis. Schizophr Res (2009) 1.01
Prediction of suicidal behavior in clinical research by lifetime suicidal ideation and behavior ascertained by the electronic Columbia-Suicide Severity Rating Scale. J Clin Psychiatry (2013) 1.01
A pharmacokinetic/pharmacodynamic study comparing a single morning dose of adderall to twice-daily dosing in children with ADHD. J Am Acad Child Adolesc Psychiatry (2003) 0.98
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report. J Clin Psychiatry (2010) 0.98
Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol (2007) 0.97
Pharmacokinetics of methylphenidate in preschoolers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2007) 0.97
A brief smell identification test discriminates between deficit and non-deficit schizophrenia. Psychiatry Res (2003) 0.94
Suicide attempts in schizophrenia: the role of command auditory hallucinations for suicide. J Clin Psychiatry (2003) 0.92
Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol (2007) 0.90
Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol (2007) 0.89
Incidence of schizophrenia among second-generation immigrants in the jerusalem perinatal cohort. Schizophr Bull (2008) 0.88
"Attenuated psychotic symptoms syndrome" as a risk syndrome of psychosis, diagnosis in DSM-V: The debate. Indian J Psychiatry (2011) 0.88
Delusions in individuals with schizophrenia: factor structure, clinical correlates, and putative neurobiology. Psychopathology (2005) 0.88
Pathways Associating Childhood Trauma to the Neurobiology of Schizophrenia. Front Psychol Behav Sci (2014) 0.88
Effect of socioeconomic status and parents' education at birth on risk of schizophrenia in offspring. Soc Psychiatry Psychiatr Epidemiol (2008) 0.86
In vivo 7 Tesla imaging of the dentate granule cell layer in schizophrenia. Schizophr Res (2013) 0.86
Low heart rate variability is not caused by typical neuroleptics in schizophrenia patients. CNS Spectr (2002) 0.85
Theory of Mind in patients at clinical high risk for psychosis. Schizophr Res (2011) 0.85
Are cognitive symptoms of schizophrenia mediated by abnormalities in emotional arousal? CNS Spectr (2002) 0.85
Maternal household crowding during pregnancy and the offspring's risk of schizophrenia. Schizophr Res (2006) 0.85
Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trials. Epilepsia (2013) 0.85
Comparable family burden in families of clinical high-risk and recent-onset psychosis patients. Early Interv Psychiatry (2008) 0.83
The utility of mandatory depression screening of dementia patients in nursing homes. Am J Psychiatry (2003) 0.83
rTMS strategies for the study and treatment of schizophrenia: a review. Int J Neuropsychopharmacol (2008) 0.82
Preliminary evidence for obesity-associated insulin resistance in adolescents without elevations of inflammatory cytokines. Diabetol Metab Syndr (2012) 0.82
Anatomical abnormalities in gray and white matter of the cortical surface in persons with schizophrenia. PLoS One (2013) 0.82
Identifying life stressors of patients with schizophrenia at hospital discharge. Psychiatr Serv (2004) 0.81
Self-reported coping strategies in families of patients in early stages of psychotic disorder: an exploratory study. Early Interv Psychiatry (2011) 0.81
Effectiveness of a cognitive behavioral weight management intervention in obese patients with psychotic disorders compared to patients with nonpsychotic disorders or no psychiatric disorders: results from a 12-month, real-world study. J Clin Psychopharmacol (2012) 0.81
Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials. J Clin Psychiatry (2016) 0.79
Validity of a 'proxy' for the deficit syndrome derived from the Positive And Negative Syndrome Scale (PANSS). Schizophr Res (2007) 0.79
Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol (2007) 0.79
Paternal age related schizophrenia and cardiac autonomic regulation profiles. Schizophr Res (2010) 0.79
Trail making and olfaction in schizophrenia: implications for processing speed. CNS Spectr (2004) 0.79
The reliability and clinical correlates of figure-ground perception in schizophrenia. J Neuropsychiatry Clin Neurosci (2004) 0.79
Critical periods and the developmental origins of disease: an epigenetic perspective of schizophrenia. Ann N Y Acad Sci (2010) 0.79
High-frequency prefrontal repetitive transcranial magnetic stimulation for the negative symptoms of schizophrenia: a case series. J ECT (2011) 0.78
Attributional style among youth at clinical risk for psychosis. Early Interv Psychiatry (2012) 0.78
Risk perception research and the black box warning for SSRIs in children. J Am Acad Child Adolesc Psychiatry (2006) 0.78
Suicidality associated with antiepileptic drugs: implications for the treatment of neuropathic pain and fibromyalgia. Pain (2013) 0.77
Using figure ground perception to examine the unitary and heterogeneity models for psychopathology in schizophrenia. Schizophr Res (2003) 0.77
Decreased suicidal ideation in depressed patients with or without comorbid posttraumatic stress disorder treated with selective serotonin reuptake inhibitors: an open study. Psychiatry Res (2012) 0.75
Marijuana and adolescence: what can we learn from primates? Am J Psychiatry (2014) 0.75
Reconceptualizing psychiatric nosology: the case of suicidal behaviour. Rev Psiquiatr Salud Ment (2009) 0.75
A case report of cognitive behavioural therapy for social anxiety in an ultra-high risk patient. Early Interv Psychiatry (2013) 0.75
Combating the Dangers of Sedentary Activity on Child and Adolescent Mental Health During the Time of COVID-19. J Am Acad Child Adolesc Psychiatry (2020) 0.75